1. Home
  2. PWOD vs ACRS Comparison

PWOD vs ACRS Comparison

Compare PWOD & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWOD
  • ACRS
  • Stock Information
  • Founded
  • PWOD 1934
  • ACRS 2012
  • Country
  • PWOD United States
  • ACRS United States
  • Employees
  • PWOD N/A
  • ACRS N/A
  • Industry
  • PWOD Major Banks
  • ACRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWOD Finance
  • ACRS Health Care
  • Exchange
  • PWOD Nasdaq
  • ACRS Nasdaq
  • Market Cap
  • PWOD 213.4M
  • ACRS 170.9M
  • IPO Year
  • PWOD N/A
  • ACRS 2015
  • Fundamental
  • Price
  • PWOD $28.21
  • ACRS $1.54
  • Analyst Decision
  • PWOD
  • ACRS Strong Buy
  • Analyst Count
  • PWOD 0
  • ACRS 7
  • Target Price
  • PWOD N/A
  • ACRS $11.67
  • AVG Volume (30 Days)
  • PWOD 18.6K
  • ACRS 1.2M
  • Earning Date
  • PWOD 04-24-2025
  • ACRS 05-06-2025
  • Dividend Yield
  • PWOD 4.56%
  • ACRS N/A
  • EPS Growth
  • PWOD 0.64
  • ACRS N/A
  • EPS
  • PWOD 2.35
  • ACRS N/A
  • Revenue
  • PWOD $68,377,000.00
  • ACRS $18,720,000.00
  • Revenue This Year
  • PWOD N/A
  • ACRS N/A
  • Revenue Next Year
  • PWOD N/A
  • ACRS $425.96
  • P/E Ratio
  • PWOD $11.95
  • ACRS N/A
  • Revenue Growth
  • PWOD 6.11
  • ACRS N/A
  • 52 Week Low
  • PWOD $17.01
  • ACRS $0.95
  • 52 Week High
  • PWOD $34.56
  • ACRS $5.17
  • Technical
  • Relative Strength Index (RSI)
  • PWOD 43.51
  • ACRS 33.57
  • Support Level
  • PWOD $27.66
  • ACRS $1.57
  • Resistance Level
  • PWOD $29.01
  • ACRS $1.78
  • Average True Range (ATR)
  • PWOD 0.64
  • ACRS 0.10
  • MACD
  • PWOD 0.06
  • ACRS 0.02
  • Stochastic Oscillator
  • PWOD 40.74
  • ACRS 25.40

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: